Dual Checkpoint Inhibition in Pancreatic Cancer: Revealing the Limitations of Synergy and the Potential of Novel Combinations
JAMA Oncol
.
2019 Oct 1;5(10):1438-1439.
doi: 10.1001/jamaoncol.2019.1583.
Authors
Arsen Osipov
1
,
Neeha Zaidi
1
,
Dan A Laheru
1
Affiliation
1
Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
PMID:
31318378
DOI:
10.1001/jamaoncol.2019.1583
No abstract available